Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,314 | 22,928 | 17,134 | 10,581 | N/A |
| Receivables | 33,404 | 28,551 | 19,656 | 18,661 | N/A |
| Inventories | 12,068 | 9,409 | 6,190 | 5,911 | N/A |
| Income taxes - deferred | 1,016 | 305 | N/A | N/A | N/A |
| Other current assets | 67,416 | 70,323 | 21,284 | 34,137 | 0 |
| TOTAL | $178,098 | $134,414 | $66,221 | $72,285 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 24,615 | 18,644 | 12,299 | 11,675 | N/A |
| Intangibles | 17,853 | 14,718 | 7,144 | 3,251 | 0 |
| Other Non-Current Assets | 378 | 392 | 1,120 | 425 | 0 |
| TOTAL | $42,846 | $33,754 | $20,563 | $15,351 | $N/A |
| Total Assets | $220,944 | $168,168 | $86,784 | $87,637 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,959 | 7,165 | 1,255 | 1,079 | N/A |
| Accounts payable and accrued liabilities | 53,284 | 30,966 | 10,306 | 22,009 | 0 |
| Accrued Expenses | 7,594 | 8,219 | 5,838 | 4,321 | N/A |
| Other current liabilities | 4,938 | 18,687 | 2,999 | 5,777 | N/A |
| TOTAL | $88,881 | $74,232 | $25,026 | $37,387 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,902 | 4,738 | 3,110 | 3,530 | N/A |
| Other Non-Current Liabilities | 2,156 | 2,029 | 0 | 0 | 0 |
| TOTAL | $13,925 | $7,422 | $3,110 | $3,530 | $N/A |
| Total Liabilities | $102,806 | $81,654 | $28,136 | $40,916 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,551 | 5,475 | 5,157 | N/A | N/A |
| Common Shares | 555 | 547 | 513 | 481 | N/A |
| Retained earnings | 75,495 | 61,345 | 50,673 | 40,306 | N/A |
| Other shareholders' equity | 16,197 | -249 | -9,810 | -7,756 | 0 |
| TOTAL | $118,138 | $86,514 | $58,648 | $46,720 | $N/A |
| Total Liabilities And Equity | $220,944 | $168,168 | $86,784 | $87,637 | $0 |